为您找到"
merial
"相关结果约100,000,000个
Boehringer Ingelheim Animal Health is a multinational animal health company formed in 2017 by merging Merial with Boehringer Ingelheim Vetmedica. Merial was a joint venture between Sanofi and Merck until 2016, and produces products and vaccines for pets, farm animals and wildlife.
More than 3,000 people power Boehringer Ingelheim Animal Health in the United States, focused on preventing disease and championing innovation.
Who we are. As a global leader in the animal health industry our more than 9,500 employees serve more than 150 markets worldwide. We are one of the largest providers of vaccines, parasiticides and therapeutics, complemented by diagnostics and monitoring platforms.
Human Health Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.
Learn how Boehringer Ingelheim Animal Health evolved from a family-owned chemical company in Germany to a global leader in animal health. Discover the milestones and mergers that shaped the company, including Merial, the animal health company founded in 1997.
DULUTH, Ga. Feb 5, 2018 - Merial, a global leader in animal health, today completes a major addition to its canine vaccine portfolio with the launch of RECOMBITEK Oral Bordetella, a conveniently packaged oral vaccine shown to be effective against canine infectious tracheobronchitis caused by Bordetella bronchiseptica.. RECOMBITEK Oral Bordetella is administered in the dog's buccal cavity ...
Merial is now owned by Boehringer Ingelheim and combined with their animal health business, Boehringer Ingelheim Vetmedica, to form Boehringer Ingelheim Animal Health. Merial produces many products and vaccines for domestic pets, farm animals and wildlife. Merial has about 6,900 employees and is present in more than 150 countries in the world. [4]
The veterinary drug makers plan to swap their human health care businesses in a deal worth $5.2 billion. The merger would create the world's second-largest animal health company, with combined sales of more than $4 billion a year.
Sanofi has sold its global animal health business, Merial, to Boehringer Ingelheim in exchange for its consumer health care business. The deal creates the second largest animal health company in the world, with combined sales of 3.8 billion euros and operations in over 150 countries.
BI becomes the second-largest animal-health company in the world after acquiring Merial from Sanofi in 2017. The deal includes parasite-control products for cattle, such as Ivomec, Eprinex and Longrange, and requires BI to divest some product lines in the U.S.